Home
Amgen AMGN paid Tarplin, Downs & Young $60K for lobbying in Q1 2023 · Health Issues, Medicare and 2 more issues
Trade details
- Type
- Lobbying report
- Amount
- $60,000
- Quarter
- Q1 2023
- Stock
- Amgen AMGN
- Client
- Amgen
- Reported
- 23/04/19
Up 0.0% from last quarter
What else happened in Amgen around then
Filed or reported within 30 days of the trade day · 23/03/01~23/04/30Amgen's other lobbying reports
- Amgen
LobbyingAmgen
LobbyingAmgen
AMGN
Under $5,000
Under $5,000
Reported 07/28
for Q2
- Amgen
LobbyingAmgen
LobbyingAmgen
AMGN
Under $5,000
Under $5,000
Reported 07/21
for Q2
- Amgen
LobbyingAmgen
LobbyingAmgen
AMGN
$50K
$50K
Reported 07/20
for Q2
- Amgen
LobbyingAmgen
LobbyingAmgen
AMGN
$80K
$80K
Reported 07/20
for Q2
- Amgen
LobbyingAmgen
LobbyingAmgen
AMGN
$60K
$60K
Reported 07/20
for Q2